Ying-Bei Chen Selected Research

Ying-Bei Chen Research Topics

Disease

51	Neoplasms (Cancer) 03/2024 - 12/2010
29	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 05/2013
9	Leiomyomatosis 01/2021 - 05/2014
8	Kidney Neoplasms (Kidney Cancer) 01/2022 - 04/2014
8	Carcinoma (Carcinomatosis) 01/2022 - 12/2010
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2010
4	Disease Progression 01/2021 - 12/2010
3	Medullary Carcinoma 12/2023 - 01/2018
3	Leiomyoma (Uterine Fibroids) 10/2017 - 05/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022 - 01/2019
2	Margins of Excision 01/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2014
2	Adenocarcinoma 01/2020 - 01/2018
2	Hereditary leiomyomatosis and renal cell cancer 01/2020 - 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 03/2024
1	Oxyphilic Adenoma (Oncocytoma) 03/2024
1	Neurofibromatoses (Neurofibromatosis) 01/2023
1	Mesothelioma 01/2023
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2023
1	Rhabdoid Tumor (Rhabdoid Tumors) 10/2022
1	Inflammation (Inflammations) 10/2022
1	Small Cell Carcinoma 10/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Urachal adenocarcinoma 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Urogenital Neoplasms 05/2021
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2021
1	Microsatellite Instability 01/2021
1	Turcot syndrome 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Lymphatic Metastasis 01/2019
1	Sickle Cell Trait 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Hemoglobinopathies 01/2018

Drug/Important Bio-Agent (IBA)

18	Fumarate Hydratase (Fumarase)IBA 12/2023 - 04/2014
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2014
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2013
8	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 12/2010
7	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2019
5	RNA (Ribonucleic Acid)IBA 10/2022 - 12/2018
5	Everolimus FDA Link 12/2020 - 11/2016
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 07/2017
3	EnzymesIBA 01/2022 - 04/2014
3	NivolumabIBA 01/2022 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2017
3	ChromatinIBA 01/2019 - 12/2010
3	TOR Serine-Threonine KinasesIBA 01/2019 - 12/2010
2	Anaplastic Lymphoma KinaseIBA 12/2023 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 11/2022 - 11/2017
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2019
2	Fluconazole (Zonal)FDA LinkGeneric 01/2022 - 08/2013
2	FumaratesIBA 01/2022 - 05/2014
2	Bevacizumab (Avastin)FDA Link 12/2020 - 11/2016
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 12/2010
2	Messenger RNA (mRNA)IBA 11/2019 - 01/2016
2	MART-1 AntigenIBA 11/2019 - 11/2017
2	AntibodiesIBA 01/2019 - 05/2013
2	SMARCB1 ProteinIBA 01/2019 - 12/2017
2	Sunitinib (Sutent)FDA Link 12/2017 - 01/2017
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 03/2024
1	Mechanistic Target of Rapamycin Complex 1IBA 03/2024
1	trans-sodium crocetinate (crocetin)IBA 03/2024
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2022
1	LigandsIBA 01/2022
1	Furylfuramide (AF2)IBA 01/2022
1	CitrullineIBA 01/2022
1	cabozantinibIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Small Cytoplasmic RNAIBA 10/2021
1	B7-H1 AntigenIBA 01/2021
1	IpilimumabIBA 01/2021
1	Cathepsin KIBA 11/2019
1	Sucrose (Saccharose)IBA 01/2019
1	temsirolimus FDA Link 01/2019
1	TensinsIBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	GlycogenIBA 01/2019
1	LipidsIBA 01/2019
1	NucleotidesIBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Sorbitol (Yal)FDA Link 01/2019
1	Sugar AlcoholsIBA 01/2019
1	HoloenzymesIBA 01/2019
1	Neurofibromin 2 (Merlin)IBA 01/2019
1	Checkpoint Kinase 2IBA 01/2019
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 05/2017
1	Oxygen (Dioxygen)IBA 05/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2017

Therapy/Procedure

25	Therapeutics 01/2023 - 05/2013
7	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2018
6	Nephrectomy 01/2022 - 10/2013
4	Immunotherapy 11/2022 - 01/2019
2	Neoadjuvant Therapy 10/2022 - 01/2022
2	Cystectomy 10/2022 - 12/2010
2	Drug Therapy (Chemotherapy) 10/2022 - 01/2021
1	Adjuvant Chemotherapy 10/2022
1	Chemoradiotherapy 10/2022
1	Precision Medicine 10/2018